Please Wait
Applying Filters...
menu
    • menu
    FDA approvals drop 24% in H1 2025; GSK’s UTI med, Vertex’s non-opioid painkiller lead pack of first-in-class meds

    Data Compilation
    #PharmaFlow

    Pipeline Prospector July 2025: Merck to acquire Verona for US$ 10 bn; FDA okays Regeneron’s blood cancer med

    Stock Recap
    #PipelineProspector

    Menu

    Topiramate (TPM)

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 171Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to access your PharmaMiles and download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    28/06/2025 Polpharma
    Poland
    		 Myungin Pharmaceutical Co., Ltd. 20130117-170-I-185-05(6) Topiramate 2020-01-13 Pharmaceutical Works Polpharma S.A. Poland 19. Pelplinska Str, 83-200 Starogard Gdanski, Poland
    28/06/2025 Polpharma
    Poland
    		 Kukjeon Pharmaceutical Co., Ltd. 20130117-170-I-185-05(4) Topiramate 2014-02-27 Pharmaceutical Works Polpharma S.A. Poland 19, Pelplinska Str. 83-200 Starogard Gdanski, Poland.